These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9489813)

  • 41. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis.
    Krause D; Schleusser B; Herborn G; Rau R
    Arthritis Rheum; 2000 Jan; 43(1):14-21. PubMed ID: 10643695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
    Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
    Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A;
    Ann Rheum Dis; 2008 Aug; 67(8):1104-10. PubMed ID: 17666447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical relapse of rheumatoid arthritis (escape phenomenon) during low-dose methotrexate therapy].
    Suzuki Y; Noguchi A; Tajima C; Uehara R; Ide M; Ichikawa Y; Mizushima Y
    Ryumachi; 1998 Feb; 38(1):6-13. PubMed ID: 9564772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
    Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy and tolerability of methotrexate in the treatment of rheumatoid arthritis].
    Pappalardo A; Sallì L; Compagno M
    Clin Ter; 1998; 149(2):109-14. PubMed ID: 9780474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
    Benito-Garcia E; Heller JE; Chibnik LB; Maher NE; Matthews HM; Bilics JA; Weinblatt ME; Shadick NA
    J Rheumatol; 2006 Jul; 33(7):1275-81. PubMed ID: 16821266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
    Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
    Dervieux T; Greenstein N; Kremer J
    Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
    Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
    J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
    Choi HK; Seeger JD; Kuntz KM
    Arthritis Rheum; 2000 Oct; 43(10):2316-27. PubMed ID: 11037892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of rheumatoid polyarthritis with methotrexate].
    Hilliquin P; Laoussadi S; Menkès CJ
    Rev Rhum Mal Osteoartic; 1991 Jun; 58(6):419-26. PubMed ID: 1896782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate.
    Rooney TW; Furst DE; Koehnke R; Burmeister L
    J Rheumatol; 1993 Aug; 20(8):1297-302. PubMed ID: 8230008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.